Prognostic Significance of Serum Albumin in Patients With Acute Coronary Syndrome

dc.contributor.authorPolat, Nihat
dc.contributor.authorOylumlu, Mustafa
dc.contributor.authorIsik, Mehmet Ali
dc.contributor.authorArslan, Bayram
dc.contributor.authorOzbek, Mehmet
dc.contributor.authorDemir, Muhammed
dc.contributor.authorKaya, Hasan
dc.date.accessioned2024-04-24T17:14:32Z
dc.date.available2024-04-24T17:14:32Z
dc.date.issued2020
dc.departmentDicle Üniversitesien_US
dc.description.abstractIn patients with unstable angina pectoris (UAP) or non-ST elevation myocardial infarction (NSTEMI), long-term mortality remains high despite improvements in the diagnosis and treatment. In this study, we investigated whether serum albumin level is a useful predictor of long-term mortality in patients with UAP/NSTEMI. Consecutive patients (n = 403) who were hospitalized with a diagnosis of UAP/NSTEMI were included in the study. Patients were divided into 2 groups based on the presence of hypoalbuminemia and the relationship between hypoalbuminemia and mortality was analyzed. Hypoalbuminemia was detected in 34% of the patients. The median follow-up period was 35 months (up to 45 months). Long-term mortality rate was 32% in the hypoalbuminemia group and 8.6% in the group with normal serum albumin levels (P< .001). On multivariate analysis, hypoalbuminemia, decreased left ventricular ejection fraction, and increased age were found to be independent predictors of mortality (P< .05). The cutoff value of 3.10 g/dL for serum albumin predicted mortality with a sensitivity of 74% and specificity of 67% (receiver-operating characteristic area under curve: 0.753, 95% CI: 0.685-0.822). All-cause long-term mortality rates were significantly increased in patients with hypoalbuminemia. On-admission albumin level was an independent predictor of mortality in patients with UAP/NSTEMI.en_US
dc.identifier.doi10.1177/0003319720941747
dc.identifier.endpage908en_US
dc.identifier.issn0003-3197
dc.identifier.issn1940-1574
dc.identifier.issue10en_US
dc.identifier.pmid32677445
dc.identifier.scopus2-s2.0-85088136658
dc.identifier.scopusqualityQ2
dc.identifier.startpage903en_US
dc.identifier.urihttps://doi.org/10.1177/0003319720941747
dc.identifier.urihttps://hdl.handle.net/11468/18035
dc.identifier.volume71en_US
dc.identifier.wosWOS:000549932500001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSage Publications Incen_US
dc.relation.ispartofAngiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAcute Coronary Syndromeen_US
dc.subjectPrognosisen_US
dc.subjectSerum Albuminen_US
dc.subjectMortalityen_US
dc.subjectRisk Predictoren_US
dc.titlePrognostic Significance of Serum Albumin in Patients With Acute Coronary Syndromeen_US
dc.titlePrognostic Significance of Serum Albumin in Patients With Acute Coronary Syndrome
dc.typeArticleen_US

Dosyalar